FDA records identify B. Braun Medical, Inc. as the applicant on two premarket notifications decided in late 2026, both cleared as Substantially Equivalent, and as the recalling firm on two Class II enforcement records. The clearances cover an intravascular administration set line and a urological irrigation set line; the recalls concern a needleless injection site valve and a stopcock extension set. The filing addresses on these records are in Bethlehem and Center Valley, Pennsylvania, and are treated here only as addresses of record, not as a verified headquarters. [1][2][3][4]

Blood administration sets cleared in October 2026

K260261, titled Gravity Blood Sets with 200µm Filter, was received by FDA on January 28, 2026, and decided Substantially Equivalent on October 22, 2026, under product code FPA and regulation number 880.5440 for intravascular administration sets. The review panel was General Hospital, the clearance type Traditional, and the record notes a Summary rather than a full statement. FDA's final-decision listing for October 2026 repeats the same device name and applicant. [1][5][9]

The manufacturer's published product page describes gravity blood administration sets with 170 micron filtration in single or dual spike designs, listing Y-type, straight, pump and hand pump configurations, and names catalog entries such as 354217 and 354218 with stated lengths and priming volumes. That page describes the marketed blood set family; it does not state that the 200µm-filtered set in K260261 is commercially available. [8]

Urological irrigation sets cleared in September 2026

K254111, titled Irrigation/Urology Sets, was received December 19, 2025, and decided Substantially Equivalent on September 10, 2026, under product code LJH, regulation number 876.5130, and the Gastroenterology/Urology review panel. The FDA decision letter is addressed to a regulatory affairs specialist at the Center Valley, Pennsylvania address of record and identifies the regulation name as Urological Catheter and accessories, Class II. [2][6][7]

The decision letter's substantial-equivalence table compares the proposed Irrigation/Urology Sets with a predicate, Baxter Irrigation Sets (K960787), and describes the proposed device as sterile, single-use and non-pyrogenic, intended for delivery of irrigation solutions from a container to an irrigation site during bladder irrigation or endoscopic procedures such as cystoscopy and transurethral resection. [6]

Recalls involving injection sites and stopcocks

Recall Z-0193-2027, classified Class II and reported October 28, 2026, covers the B Braun SAFSITE Injection Site, RV1000NC SAFSITE VALVE W/O EXTRA CAP, catalog number 415068, with 461,300 units and status Ongoing. FDA lists the reason as potential leakage and backflow at the Safsite valve, with firm-initiated voluntary action begun September 14, 2026, and distribution across listed U.S. states and Australia, Germany, Malaysia and New Zealand. [3]

Recall Z-3089-2026, classified Class II and reported September 9, 2026, covers the DISCOFIX FOUR WAY STOPCOCK, model 456025, with 25,850 units and status Ongoing. FDA lists the reason as an incorrect expiration date printed on the carton shipper label for specific lots, with firm-initiated voluntary action begun August 4, 2026, and distribution across listed U.S. states and Canada. [4]

What the filing record does and does not establish

The linked collection holds two 510(k) records, both decided Substantially Equivalent, and the smaller record sample contains the same two clearances; these counts describe the retrieved filings as of the snapshot date and are not measures of total portfolio, sales or safety performance. The two recalls are separate enforcement records and are not part of the clearance counts. [1][2][3][4]

The records do not establish corporate ownership, a verified parent or brand relationship, headquarters, customer list, certifications or commercial availability of the cleared devices. Statements about filtration and set configurations come from the manufacturer's published product page, while clearance scope and recall details come from FDA records. [5][6][8]